Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2707]
News [7018]
Articles [265]
Editorials [8]
Conferences [213]
elearning [41]
ASCO 2019 and vision for cancer control
Dr Eduardo Cazap, MD, PhD
ASCO 2019 and vision for cancer control ( Dr Eduardo Cazap, MD, PhD )
12 Jul 2019
Prof Ahmed Elzawawy on global cancer control
Dr Eduardo Cazap and Prof Ahmed Elzawawy
Prof Ahmed Elzawawy on global cancer control ( Dr Eduardo Cazap and Prof Ahmed Elzawawy )
12 Jul 2019
A new era in the early detection of cancer
Cancer Research UK
A new era in the early detection of cancer ( Cancer Research UK )
11 Jul 2019
The value of personalised medicines for healthcare systems in Europe
Anthony Barron - European Biopharmaceutical Enterprises (EBE) and the European...
The value of personalised medicines for healthcare systems in Europe ( Anthony Barron - European Biopharmaceutical Enterprises (EBE) and the European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium )
10 Jul 2019
Highlights from WIN 2019
Prof Richard Schilsky - Chief Medical Officer of ASCO and WIN Chairman
Highlights from WIN 2019 ( Prof Richard Schilsky - Chief Medical Officer of ASCO and WIN Chairman )
10 Jul 2019
Goals of the WIN Consortium
Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA
Goals of the WIN Consortium ( Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA )
10 Jul 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
Implementing national cancer control plans ( Dr Eduardo Cazap and Dr Lisa Stevens )
24 Jun 2019
Comment: POLO III trial for metastatic pancreatic cancer
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
Comment: POLO III trial for metastatic pancreatic cancer ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )
24 Jun 2019
CLL12 trial: Ibrutinib in previously untreated, asymptomatic early-stage CLL
Dr Othman Al-Sawaf - University of Cologne, Cologne, Germany
CLL12 trial: Ibrutinib in previously untreated, asymptomatic early-stage CLL ( Dr Othman Al-Sawaf - University of Cologne, Cologne, Germany )
20 Jun 2019
Chemoimmunotherapy or BTK inhibition for patients with CLL
Dr Othman Al-Sawaf - University of Cologne, Cologne, Germany
Chemoimmunotherapy or BTK inhibition for patients with CLL ( Dr Othman Al-Sawaf - University of Cologne, Cologne, Germany )
20 Jun 2019
MOR208 plus lenalidomide in r-r diffuse large B-cell lymphoma
Dr Johannes Düll - University of Würzburg, Würzburg, Germany
MOR208 plus lenalidomide in r-r diffuse large B-cell lymphoma ( Dr Johannes Düll - University of Würzburg, Würzburg, Germany )
20 Jun 2019
Blinatumomab for relapsed/refractory Burkitt's lymphoma
Dr Johannes Düll - University of Würzburg, Würzburg, Germany
Blinatumomab for relapsed/refractory Burkitt's lymphoma ( Dr Johannes Düll - University of Würzburg, Würzburg, Germany )
20 Jun 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation